OPTIVAR 500 MG BEE-HIVE STRIPS FOR HONEY BEES
OPTIVAR 500 MG BEE-HIVE STRIPS FOR HONEY BEES
Authorised
- Amitraz
Product identification
Medicine name:
OPTIVAR 500 MG BEE-HIVE STRIPS FOR HONEY BEES
Active substance:
- Amitraz
Target species:
-
Honey bee
Route of administration:
-
In-hive use
Product details
Active substance and strength:
-
Amitraz500.00/milligram(s)1.00Strip
Pharmaceutical form:
-
Bee-hive strip
Withdrawal period by route of administration:
-
In-hive use
-
Honey bee
-
Honey0dayDo not use during honey flow.
Do not extract honey from the brood chamber.
Do not harvest honey for human consumption while the treatment is in place.
Brood combs should be replaced with new foundation at least every three years.
Do not reuse brood frames as honey frames.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Heat-sealed multi-layer sachet made of two films (PE/PA/Alu/PET and PE/Alu/oPA) containing 4 strips
- Heat-sealed multi-layer sachet made of two films (PE/PA/Alu/PET and PE/Alu/oPA) containing 10 strips
- Heat-sealed multi-layer sachet made of two films (PE/PA/Alu/PET and PE/Alu/oPA) containing 12 strips
- Heat-sealed multi-layer sachet made of two films (PE/PA/Alu/PET and PE/Alu/oPA) containing 60 strips
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Bibliographic application (Article 22 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Veto-Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Veto-Pharma
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 104448/27-08-2026/K-0265601
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0515/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Romania
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/09/2026
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/09/2026
eu-puar-frv0515001-mr-rpe1052-en.pdf
English (PDF)
Download Published on: 15/09/2026
